" class="no-js "lang="en-US"> Alice Spilman Archives - Pharmtech Focus
Friday, January 27, 2023

Breaking News

Ascletis Announces IND Approval of Oral Viral Polymerase Inhibitor ASC10 for Monkeypox Indication New AI Tool Makes Speedy Gene Editing Possible European Medicines Agency accepts Marketing Authorization Application for lecanemab as treatment for early Alzheimer’s disease Syros Receives Fast Track Designation from the FDA for Tamibarotene for the Treatment of Higher-Risk Myelodysplastic Syndrome Merck Animal Health Receives U.S. FDA Approval of Expanded Indication for BRAVECTO Chews for Dogs Sharecare Launches VR Program to Improve Well-being of American Workforce Cell BioEngines Enters into an Exclusive Worldwide Agreement to Develop and Commercialize Potent Immune Cell States to Cure Cancer Nogra Pharma Announces Out-licensing Agreement with Torii Pharmaceutical for Japan for New Chemical Entity Topical Acne Treatment Cerebral Therapeutics Names Julie Foster as Chief Operating Officer Curapath Receives Accreditation as a GMP Investigational Drug Product Manufacturer from the Spanish Agency for Medicine and Health Products

Sort by:

Date

Top Post

ProPharma Acquires UK Based Digital Lab Consulting | PTF

ProPharma Acquires UK Based Digital Lab Consulting

ProPharma Group (ProPharma) the leading global provider of regulatory, clinical, and quality services for the […]

Read more

Diseases

 Healthcare is failing Gen Z - New innovation offers potential 97% saving to NHS | Pharmtech Focus

Healthcare is failing Gen Z - New innovation offers potential 97% saving to NHS

LovedBy, the health technology and consultancy business, today announces the launch of ‘Nudg with Dexcom’ […]

  1. Ascletis Announces IND Approval of Oral Viral Polymerase Inhibitor ASC10 for Monkeypox Indication

    Diseases

     Read more
  2. New AI Tool Makes Speedy Gene Editing Possible

    Diseases

     Read more
  3. European Medicines Agency accepts Marketing Authorization Application for lecanemab as treatment for early Alzheimer’s disease

    Diseases

     Read more
  4. Syros Receives Fast Track Designation from the FDA for Tamibarotene for the Treatment of Higher-Risk Myelodysplastic Syndrome

    Diseases

     Read more
  5. Merck Animal Health Receives U.S. FDA Approval of Expanded Indication for BRAVECTO Chews for Dogs

    News

     Read more